Latest Capital Markets News

NewPeak Metals has acquired the Tansey Gold Project, advanced exploration plans across Argentina and Australia, and bolstered its funding through strategic share sales in Lakes Blue Energy.

Openn Negotiation Ltd reported a significantly reduced net loss of $3.93 million for FY24, exiting voluntary administration with new directors and a recapitalisation led by ST Holding 2 Pty Ltd. The company faces challenges in regaining ASX compliance and identifying new business operations.

Complii FinTech Solutions reported an 11.8% increase in customer receipts for Q4 FY25, alongside a 4.3% quarterly rise in annual recurring revenue, underscoring its expanding footprint in capital raising and compliance software.

Rapid Critical Metals Limited (ASX, RCM) has unveiled a strategic acquisition of two high-grade silver projects in New South Wales and a critical metals project in British Columbia, supported by a proposed $10 million capital raise.

Almonty Industries has successfully priced a US$90 million upsized public offering and commenced trading on the Nasdaq, positioning itself as a key tungsten supplier for U.S. defense needs.

Larvotto Resources is exploring a USD 100 million senior secured bond to finance the restart of its Hillgrove Antimony and Gold Project, signaling a major step in advancing its mineral portfolio.

Dundee Precious Metals has published the detailed scheme document for its recommended acquisition of Adriatic Metals, setting the stage for shareholder votes in August 2025. The transaction, subject to regulatory approvals, aims to consolidate two key players in the precious metals mining sector.

Broken Hill Mines Limited has completed its acquisition of Broken Hill Mines Holdings Pty Ltd, restructured its board, and is preparing for a trading reinstatement on the ASX under the ticker 'BHM'.

Viridis Mining promotes CEO Rafael Moreno to Managing Director as the Colossus Rare Earth Project advances toward production, marking a strategic leadership shift amid key development milestones.

Cambium Bio has secured FDA clearance to begin Phase 3 dosing of Elate Ocular, a promising treatment for moderate to severe dry eye disease, pending additional financing.

Spacetalk Ltd has raised $3 million through convertible notes from its largest shareholder and converted $1 million of secured debt, positioning the company for international growth and new product development.

Chariot Corporation Ltd is set to acquire a 66.7% interest in a substantial Nigerian lithium portfolio, marking a strategic entry into Africa’s burgeoning lithium sector with a US$10 million funding commitment.